Nordea Investment Management AB Reduces Position in Avantor, Inc. (NYSE:AVTR)

Nordea Investment Management AB lessened its holdings in shares of Avantor, Inc. (NYSE:AVTR) by 81.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 63,823 shares of the company’s stock after selling 277,151 shares during the period. Nordea Investment Management AB’s holdings in Avantor were worth $1,354,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of AVTR. State Street Corp grew its stake in Avantor by 58.0% during the 3rd quarter. State Street Corp now owns 22,368,244 shares of the company’s stock valued at $578,666,000 after acquiring an additional 8,206,695 shares in the last quarter. 1832 Asset Management L.P. grew its stake in Avantor by 1,634.9% during the 2nd quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company’s stock valued at $180,839,000 after acquiring an additional 8,038,451 shares in the last quarter. The Manufacturers Life Insurance Company grew its stake in Avantor by 653.0% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 6,174,736 shares of the company’s stock valued at $159,740,000 after acquiring an additional 5,354,678 shares in the last quarter. FMR LLC grew its stake in Avantor by 557.2% during the 3rd quarter. FMR LLC now owns 4,675,283 shares of the company’s stock valued at $120,950,000 after acquiring an additional 3,963,912 shares in the last quarter. Finally, Sound Shore Management Inc. CT purchased a new stake in Avantor during the 2nd quarter valued at about $76,412,000. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Avantor Price Performance

Shares of NYSE:AVTR opened at $21.66 on Monday. The company’s fifty day moving average price is $21.52 and its 200 day moving average price is $23.35. Avantor, Inc. has a 12 month low of $19.59 and a 12 month high of $28.00. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. The firm has a market capitalization of $14.74 billion, a P/E ratio of 47.09, a P/E/G ratio of 2.75 and a beta of 1.28.

Analyst Ratings Changes

AVTR has been the subject of several analyst reports. Wells Fargo & Company dropped their price target on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research note on Monday, October 28th. Barclays lowered their price objective on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research report on Friday, October 25th. Robert W. Baird reduced their target price on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a report on Monday, October 28th. Royal Bank of Canada reiterated an “outperform” rating and set a $34.00 target price on shares of Avantor in a report on Thursday, September 26th. Finally, UBS Group reduced their target price on shares of Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a report on Tuesday, October 8th. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to MarketBeat.com, Avantor has an average rating of “Moderate Buy” and a consensus target price of $27.69.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.